BioNexus Gene Lab Corp. – NASDAQ:BGLC

Add to watchlist

$5.27

+5.00

+1871.57%

Market closed

Open in 4 minutes

-47.21%

month

-47.21%

quarter

-51.45%

year

Market Cap	4.37M
Enterprise value	91.07M

P/E	-1518.66
EV/Sales	5.53
EV/EBITDA	-253.53
Price/Sales	5.57
Price/Book	13.74
PEG ratio	3392753.60
EPS	-0.16

Revenue	9.77M
EBITDA	-2.71M
Income	-2.66M
Revenue Q/Q	0.19%
Revenue Y/Y	-4.87%

Profit margin	-0.37%
Oper. margin	-2.4%
Gross margin	11.17%
EBIT margin	-2.4%
EBITDA margin	-27.73%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Profit margin
Jun 2023	2.56M	-259.25K	-10.1%
Sep 2023	2.55M	-2.60M	-102.13%
Dec 2023	2.27M	307.41K	13.52%
Mar 2024	2.38M	-103.75K	-4.36%

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Payout ratio
Payout ratio	0%

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Dividend Yield
2019
2020	0%
2021	0.01%
2022	0.07%
2023

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Debt to assets
Jun 2023	7898940	1.93M	24.5%
Sep 2023	11465522	1.77M	15.51%
Dec 2023	11399793	1.74M	15.28%
Mar 2024	11161483	1.81M	16.28%

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Cash Flow
Jun 2023	-22.04K	-3.05K	-4.21K
Sep 2023	-899.34K	-360.71K	5.74M
Dec 2023	-261.90K	-13.75K	11.11K
Mar 2024	-28.20K	15.15K	26.93K

BioNexus Gene Lab Corp. alternative data

BioNexus Gene Lab Corp.
Employees

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Employee count
Aug 2023	27
Sep 2023	27
Oct 2023	27
Nov 2023	27
Dec 2023	27
Jan 2024	27
Feb 2024	27
Mar 2024	27
Apr 2024	27
May 2024	30
Jun 2024	30
Jul 2024	30

BioNexus Gene Lab Corp.
Latest News

Wednesday, 25 September 2024
11:31	BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.	globenewswire.com
Friday, 13 September 2024
12:05	BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.	globenewswire.com
Thursday, 12 September 2024
13:23	BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions	globenewswire.com
Wednesday, 11 September 2024
11:05	BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production	globenewswire.com
Tuesday, 27 August 2024
11:35	BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd	globenewswire.com
Monday, 26 August 2024
12:15	BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd	globenewswire.com
Friday, 19 April 2024
08:58	Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?	investorplace.com
Thursday, 18 April 2024
14:52	BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare	globenewswire.com
Tuesday, 13 February 2024
11:14	Why Is BioNexus (BGLC) Stock Up 323% Today?	InvestorPlace

Frequently Asked Questions (FAQ)

What's the price of BioNexus Gene Lab Corp. stock today?

One share of BioNexus Gene Lab Corp. stock can currently be purchased for approximately $5.27.
When is BioNexus Gene Lab Corp.'s next earnings date?

Unfortunately, BioNexus Gene Lab Corp.'s (BGLC) next earnings date is currently unknown.
Does BioNexus Gene Lab Corp. pay dividends?

No, BioNexus Gene Lab Corp. does not pay dividends.
How much money does BioNexus Gene Lab Corp. make?

BioNexus Gene Lab Corp. has a market capitalization of 4.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10.6% to 9.77M US dollars.
What is BioNexus Gene Lab Corp.'s stock symbol?

BioNexus Gene Lab Corp. is traded on the NASDAQ under the ticker symbol "BGLC".
What is BioNexus Gene Lab Corp.'s primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of BioNexus Gene Lab Corp.?

Shares of BioNexus Gene Lab Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does BioNexus Gene Lab Corp. have?

As Jul 2024, BioNexus Gene Lab Corp. employs 30 workers, which is 11% more then previous quarter.
When BioNexus Gene Lab Corp. went public?

BioNexus Gene Lab Corp. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.
What is BioNexus Gene Lab Corp.'s official website?

The official website for BioNexus Gene Lab Corp. is bionexusgenelab.com.
How can i contact BioNexus Gene Lab Corp.?

BioNexus Gene Lab Corp. can be reached via phone at +60 12 212 6512.

BioNexus Gene Lab Corp.

bionexusgenelab.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

+60 12 212 6512

Tower B, Vertical Business Suite
Kuala Lumpur, 59200

CIK: 0001737523
ISIN: US0906282076
CUSIP: 090628108